The Medical Research Council (MRC) is announcing an investment of £20M for capital only funding which will support research addressing the key translational bottlenecks identified through the Strategy for UK Regenerative Medicine. It is envisaged that this funding will complement recent strategic investments, including the UK Regenerative Medicine Platform. Building on existing institutional strengths, successful bids will provide or enhance national capabilities to meet the challenges identified in the UK strategy.

Further information on the call and details of how to submit an application are available on the MRC Call for proposals page